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EDITORIAL Open Access
Implementation Science six years on—our
evolving scope and common reasons for
rejection without review
Martin P Eccles1*, Robbie Foy2, Anne Sales3, Michel Wensing4 and Brian Mittman5
Abstract
Implementation Science has been published for six years and over that time has gone from receiving 100 articles in
2006 to receiving 354 in 2011; our impact factor has risen from 2.49 in June 2010 to 3.10 in June 2012. Whilst our
article publication rate has also risen, it has risen much less slowly than our submission rate—we published 29
papers in 2006 and 134 papers in 2011 and we now publish only around 40 % of submissions. About one-half of
submitted manuscripts are rejected without being sent out for peer review; it has become clear that there are a
number of common issues that result in manuscripts being rejected at this stage. We hope that by publishing this
editorial on our common reasons for rejection without peer review we can help authors to better judge the
relevance of their papers to Implementation Science.
Background
Implementation Science has been published for six years
and over that time has gone from receiving 100 articles
in 2006 to receiving 354 in 2011; our impact factor has
risen from 2.49 in June 2010 to 3.10 in June 2012.
Whilst our article publication rate has also risen, it has
risen much less slowly than our submission rate—we
published 29 papers in 2006 and 134 papers in 2011 and
we now publish fewer than 40 % of submissions. About
one-half of submitted manuscripts are rejected without
being sent out for peer review; it has become clear that
there are a number of common issues that result in
manuscripts being rejected at this stage. We set these
out in order to help authors considering submitting to
Implementation Science. They are summarized in Table 1
and addressed in the remainder of this article. In estab-
lishing and applying the criteria in Table 1, we endeavor
to maintain consistency in our decisions irrespective of
the clinical focus, approach to healthcare delivery, or set-
ting involved in the manuscript. We are aware that we
do not necessarily get it right all of the time; authors can
help us make the right decisions on their manuscripts by
making clear statements about, for example, the appro-
priateness of their study design and what the article adds
to current knowledge or methodology.
Journal scope
We receive a number of manuscripts that are not within
our scope. Some are far outside our scope (e.g., evalua-
tions of novel clinical interventions), but others are more
difficult to judge (e.g., evaluations of novel service deliv-
ery methods). As one part of resolving a number of
these more difficult or marginal issues we have, in dis-
cussion with our Senior Advisory Board and Editorial
Board, refined our scope, particularly in relation
to organizational, policy, and population-focused
interventions.
This clarified a number of points:
 Our enduring field of interest is healthcare and
evidence-based healthcare practice; we are
interested in studies that report findings that would
be of interest to a healthcare policy or decision
maker, and in which there is a plausible connection,
even distally, to health outcomes for patients;
 Our continuing principal interest in implementation
strategies aimed at clinicians or clinical teams, and
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their organisations including strategies that imply a
more active role for patients (see below);
 Clearer specification of our interest in the study of
evidence-based organisational strategies as a method
of introducing evidence-based healthcare;
 Clarification of the eligibility of public health
interventions involving healthcare or healthcare
professionals: public health papers that are
evaluating the effectiveness of the introduction of
health-related practices (of known effectiveness) are
within our scope;
 Our interest in publishing generalizable findings (see
below);
 Our exclusion of studies that are primarily
concerned with establishing the effectiveness of a
clinical or organisational intervention rather than
the effectiveness of its implementation.
Our revised scope is
‘Implementation Science is an open access, peer-
reviewed online journal that aims to publish research
relevant to the scientific study of methods to promote
the uptake of research findings into routine healthcare
in clinical, organisational, or policy contexts.
‘Biomedical, social science, organisational, and man-
agerial research constantly produce new findings—but
often these are not routinely translated into healthcare
practice. Implementation research is the scientific study
of methods to promote the systematic uptake of proven
clinical treatments, practices, organisational, and man-
agement interventions into routine practice, and hence
to improve health. In this context, it includes the study
of influences on patient, healthcare professional, and or-
ganisational behaviour in either healthcare or population
settings.
Table 1 Summary of issues that influence the likelihood rejection without review of articles submitted to
Implementation Science
Issue Likely to be accepted Likely to be rejected
Field of interest Healthcare and public health Anything else
Effectiveness studies Evaluating the introduction of an
intervention/evidence-based practice
of known effectiveness
Evaluating the effectiveness of a
clinical, organizational, public health,
or policy intervention
Outcome Health or health-related Anything else
Implementation Researching implementation Doing implementation
Validity Maximizes internal and external
validity as appropriate in the chosen
study designs
Patient decision aids Evaluations of the introduction of patient
decision aids (of known effectiveness) into
healthcare care settings; involvement of
healthcare providers
Initial development or pilot testing
of patient decision aids
Implementation (Knowledge Translation)
direct to patients
Outcomes referring to evidence-based
practice with some involvement of
healthcare providers
Other types of outcomes
Intervention development reports Prepared and submitted prior to the reporting
of the effectiveness of the intervention
Post hoc submission
Going to be, (robustly) evaluated Not going to be (robustly) evaluated
Process evaluation Submitted contemporaneously with or
following report of intervention effectiveness
Process evaluations submitted in advance of the
conduct of the main effectiveness analysis
(it cannot be clear if they are explaining an
effect or the absence of an effect)
Process evaluations that take account of
the main evaluation outcomes
Process evaluations that do not take account of
the main evaluation outcomes
Pilot studies If appropriate criteria for conduct No justification for conduct
If appropriate degree of inference Overclaim on basis of results
If there are plans for further evaluation
Protocols Been through (inter)national level peer
review as part of their funding
Not been through national level peer review
as part of their funding
Received ethics review board approval Not received ethics review board approval
Submitted prior to data cleaning or analysis Have begun data cleaning or analysis
(may not apply to some qualitative studies)
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‘The lack of routine uptake of research findings is stra-
tegically important for the development of healthcare
because it clearly places an invisible ceiling on the po-
tential for research to enhance health. Further, it is sci-
entifically important because it identifies the behaviour
of healthcare professionals and healthcare organisations
as key sources of variance requiring improved empirical
and theoretical understanding before effective uptake
can be reliably achieved.
‘Implementation science is an inherently interdisciplin-
ary research area, and the journal is not constrained by
any particular research method. Implementation Science
wishes to publish articles of high scientific rigour using
the most appropriate methods to produce valid, general-
isable answers to research questions. As well as hosting
papers describing the effectiveness of implementation
interventions, Implementation Science provides a unique
home for articles describing intervention development,
evaluations of the process by which effects are achieved,
and the role of theory relevant to implementation re-
search. The journal is also interested in publishing arti-
cles that present novel methods (particularly those that
have a theoretical basis) for studying implementation
processes and interventions. We are also interested in
receiving articles that address methodologically robust
study of the de-implementation of ineffective clinical
and organisational practices.
‘We welcome study protocols, but these will only be
considered if the study has received ethics approval and
been through external peer review via an established
funding body. We do not consider protocols for system-
atic reviews or protocols for quantitative studies that
have begun data cleaning or analysis.’
Alongside elaborating some of the issues coming out
of this process, we also take this opportunity to address
a number of common specific content and methodo-
logical issues that frequently lead us to reject a paper.
Is it implementation research?
With our revised scope, our first major editorial ques-
tion is ‘Is it implementation research?’ We expect a
manuscript to deal with studying, as opposed to con-
ducting, implementation—to be concerned with imple-
mentation science rather than implementation practice.
Without a scientific question focused on implementation
research, a manuscript will not be within our scope.
We accept six types of papers: Research, Systematic
Review, Protocol, Methodology, Short Reports, and De-
bate. We no longer accept Meeting Reports. In general
we expect Research, Systematic Review, Protocol, and
Short Report manuscripts to focus on the formative (in-
cluding research on implementation barriers, facilitators,
and processes) or summative evaluation of the imple-
mentation of a defined, evidence-based, clinical practice,
organizational, or policy intervention. Similarly, we
would expect Methodology and Debate articles to focus
on the methods for studying such implementation, or
debate of key conceptual, theoretical, or methodological
issues in the field. We understand that what is consid-
ered to be evidence-based and thus appropriate for im-
plementation may vary, given the ongoing and complex
debates about the nature of evidence, but authors need
to make their arguments in relation to this very clear.
Our judgment is informed by how authors contextualize
and situate their manuscript within the existing litera-
ture—whether or not the manuscript’s background section
identifies and discusses the relevant implementation sci-
ence literature (including systematic reviews) as appropri-
ate, and whether or not the aims (and discussion) include
an explicit statement about what the paper adds to exist-
ing knowledge, research, or research methods. We recom-
mend that authors consider drafting a short paragraph
that begins ‘Our study adds the following new information
or knowledge to the existing literature. . .’ as a method of
ensuring that this is clearly communicated.
There are two other scope issues that are linked—im-
plementation strategies directed to patients without in-
volvement of healthcare providers or the healthcare
system, and decision aids.
Implementation directed to patients
The Cochrane Effective Practice and Organisation of Care
(EPOC) Review Group criteria offer a useful basis for our
policy regarding patient-directed implementation; they
allow patient mediated interventions defined as follows:
‘Interventions that aim to influence professional prac-
tice through patients are within the scope of EPOC.
However, interventions that are solely aimed at changing
the behaviour of consumers, such as lifestyle counseling,
are not within EPOC's scope, unless both professional
and patient behaviour is affected, for example interven-
tions that aim to improve smoking cessation counseling
by professionals where smoking cessation is the primary
outcome measure, or interventions aimed at improving
professionals' management of hypertension or diabetes
where blood pressure or blood sugar control, respect-
ively, is the primary outcome measure.’ (EPOC
Taxonomy http://epoc.cochrane.org/information-specific-
epoc-reviews accessed July 12 2012)
In general we adopt an EPOC-like position. However,
we need some degree of flexibility. Consider a situation
where a secondary care clinician and a policy maker say
‘we have a large problem with identification, diagnosis,
and management of problems with continence in older
women. We know they don’t present to primary care, and
when they do primary care doctors don’t manage it.’ They
mount a trial where they mail (evidence-based) guidelines
on pelvic floor exercises directly to women over the age of
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55 years. The trial shows an effect on care processes, in-
cluding an increase in appropriate identification, diagno-
sis, and/or management by primary care clinicians. The
policy maker then has an evidence-based guideline and an
evidence-based implementation strategy that is policy rele-
vant and generalizable to any area that has poor primary
healthcare provision and a postal service.
The issue of women not presenting for care is a health
promotion issue or a clinical issue depending on per-
spective. The issue of primary care doctors not dealing
with it is an implementation issue. If the healthcare pro-
fessional (primary care doctor in this case) is a barrier,
then we can see a policy maker expressing interest in an
effective patient-mediated implementation strategy. This
does not mean that in another setting a policy maker
would not want to address the issue by intervening with
primary care doctors directly—but the result is still the
implementation of a guideline with benefits in improved
clinical processes and outcomes. If an author articulates
all of these points, then we are more likely to consider
such a study within scope.
We are interested in evaluations of the introduction of
patient decision aids (of known effectiveness) into rou-
tine care settings. These studies will usually involve mul-
tiple routine care settings, usually with multiple
healthcare professionals and unselected patient popula-
tions. We regard the initial development or pilot testing
of patient decision aids as out of scope. Some emerging
trends in shared decision-making research that go well
beyond the application of decision aids in practice, such
as implementation of inter-professional shared decision-
making practice involving substantial change in health
professional behavior and/or system of care, would likely
be within scope.
Generalisability
As well as being interested in internal validity, we are
very interested in studies that produce clearly
generalizable results (have high external validity), or that
provide evidence of transferability across settings. We
would like the readers of Implementation Science to be
able to read a description of a study and, when they try
and replicate it, have some a priori idea of what will
happen as a consequence.
We do not impose methodological criteria for how
authors might achieve this, but a variety of designs are
available: pragmatic (cluster) randomized controlled
trials (RCTs), interrupted time series studies, multiple
case studies, case studies and qualitative research with a
strong (explicit and a priori) theoretical underpinning.
Intervention development reports
We welcome articles describing implementation interven-
tion development in the context of an ongoing or
subsequent evaluation of the effectiveness of the interven-
tion. In general, implementation intervention develop-
ment reports, like protocols, should be prepared and
submitted prior to reporting the effectiveness of the inter-
vention. If authors wished to publish an intervention de-
velopment report after the publication of its effects are
known, they would have to make a clear and strong argu-
ment for why such an intervention description merited
publication and address why it had not been described a
priori. To do otherwise risks authors modifying (con-
sciously or not) their description of an intervention in the
light of their knowledge of its effectiveness.
We receive a number of papers describing intervention
development where the plan is to subsequently intro-
duce the intervention without evaluation (i.e., a case
study) or a weak evaluation design that cannot rule out
a multitude of alternative explanations for observed
effects (e.g., a single site after or before/after design). We
do not accept these.
Methodological and conceptual studies
We often receive manuscripts aiming to report novel
methodological approaches or new conceptual frame-
works relevant to implementation research. We welcome
any such work that aims to advance our science. How-
ever, we often end up rejecting such submissions where
it is unclear what the methodological development or
(yet) another conceptual framework adds to existing lit-
erature. It is important that authors considering submit-
ting such articles ensure that they have argued the
reasons for choosing their method/theory/framework in-
stead of the plausible alternatives.
Process evaluations of interventions
In general, we encourage the submission of process eva-
luations—studies of what mediates or moderates the
effects of an intervention. However, a process evaluation
is useful only when reported alongside the implementa-
tion intervention it aims to explain. Whilst this can hap-
pen either in a main report paper or in a simultaneous
paper, if they are in separate papers then ideally any
journal should be considering both manuscripts. Most
importantly, the editor needs to know what the main
outcomes in the trial were in order to understand the
measures used in the process evaluation.
We do not accept:
 Process evaluations submitted in advance of the
conduct of the main effectiveness analysis, because it
cannot be clear if they are explaining an effect or
the absence of an effect;
 Process evaluations that do not take account of the
main evaluation outcomes.
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Pilot studies
Implementation Science will consider appropriately
designed and configured pilot studies. Our general
principle is to use the same criteria that would be applied
to a funding decision. For example, a small study would
be useful if little or no evidence exists in a given area and
the risk involved in a larger study is too great, and if the
small study minimizes bias and assures basic levels of val-
idity, even if the confidence interval around the results
turns out to be large. If better evidence exists, then a small
study will generally be of little value and will be difficult to
justify as a contribution to existing knowledge.
An exception to this rule may be when a pilot is con-
ducted with the explicit purpose of assessing feasibility
and planning for a complex intervention that is expected
to contribute to existing knowledge, as described in the
UK Medical Research Council updated guidance on
evaluating complex interventions [1], or in the Veterans
Affairs Quality Enhancement Research Initiative
(QUERI) framework for planning a national level imple-
mentation project [2]. In this case, if the goals of the
pilot include the following, and provide potentially
generalizable knowledge, we may be interested in pub-
lishing a report: development of a protocol for a com-
plex intervention with description of acceptability, new
techniques, specific issues of recruitment and consent;
development of new measures; interesting methods or
issues related to randomization; and sample size calcula-
tion, including estimation of intraclass correlation in the
case of clustered data [3]. In most cases, we would ex-
pect reports of pilot studies to be relatively brief, and
typically appropriate for the Short Report format.
If a manuscript describing a pilot study is being con-
sidered, then it is very important that the authors report
it as such with due caution in relation to the provisional
nature of the results and, in the context of a ‘successful’
pilot, preferably indicating how a subsequent study will
draw from the pilot study.
Qualitative studies
We frequently receive papers using qualitative methods
for data collection and analysis. Many of these are of
high quality, and we publish those that fit our scope and
meet applicable criteria for quality and validity. However,
we often find problems in the reporting or design quality
of papers using qualitative methods, or in the clarity of
their contribution to existing knowledge. Not infre-
quently, we receive papers that report on essentially con-
tent analysis of interviews, often without appropriate
links to relevant theory or without contextualization.
We routinely reject these.
We currently recommend use of the RATS guidelines
for assessing minimal quality of reporting of qualitative re-
search (http://www.biomedcentral.com/ifora/rats accessed
6 July 2012), which we also advise our reviewers to con-
sider as they review qualitative papers. In addition to using
RATS as a check prior to submission, however, we also
encourage authors to read some of the literature that
forms a backdrop to what is a very lively ongoing debate
and discussion about what constitutes high-quality report-
ing of studies using qualitative methods [4,5]. We note in
particular that high-quality reporting of research using
qualitative methods requires some amount of reflection
about the epistemology underlying the choice of methods,
as well as clear and comprehensive description of the con-
text or setting in which the study was conducted and in
which the participants exist.
Reporting guidelines
Our instructions to authors already state our support for
reporting guidelines, but it is worth re-stating here be-
cause many authors seem not to use them. Where avail-
able, methodological assessment and adequacy of
reporting should be judged against relevant reporting
guidelines. Whilst there are many reporting guidelines
(see http://www.equator-network.org/home/ accessed 6
July 2012), those of particular relevance to Implementa-
tion Science are (http://www.implementationscience.
com/about):
 Trials—CONSORT, particularly the extension for
cluster trials;
 Systematic review—PRISMA;
 Qualitative studies—RATS;
 Surveys—Reporting guidelines for survey research
[6];
 Intervention reporting—http://www.
implementationscience.com/content/4/1/40.
For RCTs and systematic reviews, respectively, CON-
SORT (with the extension for cluster trials) and
PRISMA checklists should be completed and uploaded
as an additional file for the editor to check, and authors
should also include a flowchart as part of the manu-
script. In addition, authors should make any amend-
ments identified on the basis of completing the
checklist.
Whilst CONSORT applies specifically to RCTs,
authors of studies using other evaluative designs would
be well advised to consult the reporting guidelines be-
cause many of the issues can, with benefit, be applied to
non-randomised studies.
Protocols
Our policy regarding publication of protocols has recently
changed and, so again, whilst this is reflected in our jour-
nal web pages, it is worth re-stating here. The case for
publishing protocols is most clearly made for trials.
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Although some of the ‘advertising’ arguments can apply to
studies using other designs, the a priori statement of study
outcome measures and analyses is important for trials.
Many of the protocols we currently publish are for trials,
and though we do publish protocols for study designs
other than trials, this is currently under review. We would
be interested in readers’ views on the publication of proto-
cols for studies other than trials.
We accept (without further peer review) protocols that
have been through (at least) national level, competitive
peer review as part of their funding and that have
received ethics review board approval or exemption.
Protocols for programs of research may be an exception
to this requirement and are considered on a case-by-
case basis.
We do not accept:
 Protocols that have not been the subject of national
or international level peer review as part of funding;
 Protocols for pilot studies—Because pilot studies are
intended to lead on to subsequent, larger studies
then there will be considerable overlap between the
content of protocols for the two, and concerns
about duplicate publication then arise. Authors
should concentrate on publishing protocols for their
subsequent, larger studies;
 Protocols for systematic reviews—We refer
systematic review protocols to the new BMC
journal, Systematic Reviews;
 Protocols that are submitted for studies (particularly
cluster RCTs) where data cleaning and analysis have
begun. Having a cut point like this is a common
requirement of journals that publish trial protocols
(in clinical trials, it is usually the end of patient
recruitment) so that publication is a truly
prospective event and the content of a protocol
cannot be influenced (however unlikely this might
be) by knowledge of the data. This may not apply to
some qualitative studies but, in general, the
intention is for a protocol to be published prior to
any analysis in order to prevent bias.
Authors of trial protocols also need to have registered
the study with an appropriate trial database and to
complete an appropriate reporting guideline checklist
(see section above on reporting guidelines).
Conclusions
We hope that by publishing this editorial on our com-
mon reasons for rejection without peer review we can
help authors to better judge the appropriateness of their
papers to Implementation Science. We will continue to
review and refine our policies as the journal and the
research field continue to evolve, and welcome author
and reader comments and debate to guide this review.
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